Lewis Milrod
Neurology · Edison, NJNPI 1851317572
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 335 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 28.9% of the total.
Across 335 payments — averaging $14.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$1K
- UCB, Inc.$869
- Tris Pharma Inc$565
- Corium, LLC$382
- Collegium Pharmaceutical, Inc.$173
- Upsher-smith Laboratories LLC$151
- plus $1K from 24 others
What the payments were for
- Food & beverage$4,709100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 93 | $1,364 |
| UCB, Inc. | 41 | $869 |
| Tris Pharma Inc | 65 | $565 |
| Corium, LLC | 30 | $382 |
| Collegium Pharmaceutical, Inc. | 13 | $173 |
| Upsher-smith Laboratories LLC | 11 | $151 |
| Ironshore Pharmaceuticals Inc. | 10 | $144 |
| Neos Therapeutics, LP | 9 | $132 |
| Adlon Therapeutics L.p. | 7 | $99 |
| Jazz Pharmaceuticals Inc. | 6 | $87 |
| Aquestive Therapeutics, Inc. | 5 | $80 |
| Sunovion Pharmaceuticals Inc. | 6 | $72 |
| Rhodes Pharmaceuticals L.p. | 5 | $68 |
| Neurelis, Inc. | 3 | $66 |
| Aprecia Pharmaceuticals, LLC | 4 | $61 |
| Eisai Inc. | 4 | $59 |
| Harmony Biosciences LLC | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $57 |
| Greenwich Biosciences, Inc. | 3 | $43 |
| Biogen | 2 | $36 |
| Vertical Pharmaceuticals, LLC | 2 | $28 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Avion Pharmaceuticals | 1 | $15 |
| OWP Pharmaceuticals, Inc. | 1 | $15 |
| Livanova USA, Inc. | 1 | $14 |
| Zogenix Inc. | 1 | $14 |
| Mallinckrodt Enterprises LLC | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Metacel Pharmaceuticals LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,716 in reported general payments places this provider in the 65th percentile of 521 neurology providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Paroxetine Hcl | 11 | $64 |
Paid to pharmacies, not to this prescriber.
Other neurology in Edison
- Marina SobolEdison$69K
- Igor SobolEdison$55K
- Wei Wei MaEdison$39K
- Steven BromleyAudubon$1.5M
- Mary Ann PiconeTeaneck$1.5M
- Fiona GuptaOradell$1.1M
- Matthew DavisMiddletown$567K
- Amos KatzEatontown$558K
- Monte PellmarFreehold$429K
- Marcie RabinSummit$387K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.